These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20386425)

  • 1. Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.
    Lawn SD; Kranzer K; Edwards DJ; McNally M; Bekker LG; Wood R
    AIDS; 2010 Jun; 24(9):1323-8. PubMed ID: 20386425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.
    Lawn SD; Myer L; Edwards D; Bekker LG; Wood R
    AIDS; 2009 Aug; 23(13):1717-25. PubMed ID: 19461502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.
    Lawn SD; Myer L; Bekker LG; Wood R
    AIDS; 2007 Jan; 21(3):335-41. PubMed ID: 17255740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.
    Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M
    BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.
    Gupta-Wright A; Wood R; Bekker LG; Lawn SD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):261-70. PubMed ID: 23846570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008.
    Auld AF; Mbofana F; Shiraishi RW; Alfredo C; Sanchez M; Ellerbrock TV; Nelson LJ
    PLoS One; 2013; 8(1):e54665. PubMed ID: 23349948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy.
    Kufa T; Chihota V; Mngomezulu V; Charalambous S; Verver S; Churchyard G; Borgdorff M
    BMC Infect Dis; 2016 Jun; 16():266. PubMed ID: 27286814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.
    Van Rie A; Westreich D; Sanne I
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):349-55. PubMed ID: 20926954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in HIV-infected Tanzanian children below 14 years.
    Njau JC; Aboud S
    East Afr J Public Health; 2010 Sep; 7(3):199-205. PubMed ID: 21516954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; van Wyk G; Vogt M; Pahlana P; Nicol MP; Meintjes G
    BMC Med; 2015 Aug; 13():192. PubMed ID: 26275908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.
    Worodria W; Massinga-Loembe M; Mayanja-Kizza H; Namaganda J; Kambugu A; Manabe YC; Kestens L; Colebunders R
    Clin Dev Immunol; 2011; 2011():758350. PubMed ID: 21197091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
    Komati S; Shaw PA; Stubbs N; Mathibedi MJ; Malan L; Sangweni P; Metcalf JA; Masur H; Hassim S
    AIDS; 2010 Jul; 24(12):1849-55. PubMed ID: 20622529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
    Lawn SD; Myer L; Bekker LG; Wood R
    AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa.
    Lawn SD; Campbell L; Kaplan R; Boulle A; Cornell M; Kerschberger B; Morrow C; Little F; Egger M; Wood R;
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):136-40. PubMed ID: 21436714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding.
    Hanifa Y; Fielding KL; Charalambous S; Variava E; Luke B; Churchyard GJ; Grant AD
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1252-9. PubMed ID: 22794030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening.
    Oni T; Burke R; Tsekela R; Bangani N; Seldon R; Gideon HP; Wood K; Wilkinson KA; Ottenhoff TH; Wilkinson RJ
    Thorax; 2011 Aug; 66(8):669-73. PubMed ID: 21632522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.